Literature DB >> 24528104

Should we stop prescribing pioglitazone?

Panagiotis Anagnostis1, Spyridon N Karras.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24528104      PMCID： PMC4137839          DOI： 10.1111/bcp.12342

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

Review 1.  Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control.

Authors:  P Anagnostis; V G Athyros; F Adamidou; A Panagiotou; M Kita; A Karagiannis; D P Mikhailidis
Journal:  Diabetes Obes Metab       Date:  2011-04       Impact factor: 6.577

Review 2.  Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality.

Authors:  Steven E Nissen; Kathy Wolski
Journal:  Arch Intern Med       Date:  2010-07-26

3.  Observational follow-up of the PROactive study: a 6-year update.

Authors:  E Erdmann; E Song; R Spanheimer; A-R van Troostenburg de Bruyn; A Perez
Journal:  Diabetes Obes Metab       Date:  2013-08-19       Impact factor: 6.577

4.  Thiazolidinediones and associated risk of bladder cancer: a systematic review and meta-analysis.

Authors:  Richard M Turner; Chun S Kwok; Chen Chen-Turner; Chinedu A Maduakor; Sonal Singh; Yoon K Loke
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

Review 5.  PROactive: time for a critical appraisal.

Authors:  D John Betteridge; Ralph A DeFronzo; Robert J Chilton
Journal:  Eur Heart J       Date:  2008-03-28       Impact factor: 29.983

Review 6.  Comparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studies.

Authors:  Yoon Kong Loke; Chun Shing Kwok; Sonal Singh
Journal:  BMJ       Date:  2011-03-17
  6 in total
  1 in total

1.  Combined intervention with pioglitazone and n-3 fatty acids in metformin-treated type 2 diabetic patients: improvement of lipid metabolism.

Authors:  Jiri Veleba; Jan Kopecky; Petra Janovska; Ondrej Kuda; Olga Horakova; Hana Malinska; Ludmila Kazdova; Olena Oliyarnyk; Vojtech Skop; Jaroslava Trnovska; Milan Hajek; Antonin Skoch; Pavel Flachs; Kristina Bardova; Martin Rossmeisl; Josune Olza; Gabriela Salim de Castro; Philip C Calder; Alzbeta Gardlo; Eva Fiserova; Jørgen Jensen; Morten Bryhn; Jan Kopecky; Terezie Pelikanova
Journal:  Nutr Metab (Lond)       Date:  2015-12-02       Impact factor: 4.169
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.